| EMA number | EMEA/H/C/000353 |
| ATC code | L01XC04 |
| Authorisation | 6 July 2001 |
| Withdrawn | 8 August 2012 |
| Revision | 14 |
MabCampath is indicated for the treatment of patients with B-cell chronic lymphocytic leukaemia (BCLL) for whom fludarabine combination chemotherapy is not appropriate.